Related Experiment Videos

Flow cytometric quantification of phagocytosis in acute myeloid leukemia

C F Bassoe1

  • 1Medical Department and Gade Institute, Department of Pathology, Haukeland University Hospital, and PROMED Institute, Bergen, Norway.

Acta Haematologica
|March 22, 2000
PubMed

Insights

Phagocytosis is impaired in acute myeloid leukemia (AML) despite some immature leukemic cells compensating. This receptor-dependent process involves functional complement receptors on both immature and mature AML leukocytes.

Area of Science:

  • Immunology
  • Hematology
  • Cell Biology

Background:

  • Phagocytosis is a critical cellular process for immune defense and tissue homeostasis.
  • Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the accumulation of immature myeloid blasts.
  • Dysfunctional immune cells are a hallmark of the leukemic environment, potentially impacting phagocytic activity.

Purpose of the Study:

  • To investigate and characterize the phagocytic activity of leukocytes in patients with acute myeloid leukemia (AML).
  • To compare phagocytosis patterns between AML patients and healthy controls.
  • To elucidate the mechanisms and cellular components involved in phagocytosis within the AML context.

Main Methods:

  • Flow cytometry (FCM) was employed to quantify and analyze phagocytosis.
  • Comparative analysis was performed between 15 AML patients and control subjects.
  • Assessment included receptor dependency and the role of complement receptors.

Main Results:

  • Leukocytes from AML patients exhibited significantly reduced phagocytosis compared to controls (p < 0.01).
  • A subpopulation of leukemic cells showed diminished phagocytic capacity.
  • Immature leukocytes in AML compensated by phagocytosing multiple targets, indicating a complex functional alteration.
  • Phagocytosis in both immature and mature AML leukocytes was receptor-dependent and involved functional complement receptors.
  • Cell surface attachment was not identified as a rate-limiting factor in AML phagocytosis.

Conclusions:

  • Phagocytosis is significantly altered in acute myeloid leukemia, with an overall decrease in activity.
  • Immature leukemic leukocytes display compensatory phagocytic behaviors, suggesting a complex interplay of functional deficits and adaptations.
  • The receptor-dependent nature of phagocytosis, involving complement receptors, highlights potential therapeutic targets in AML immunotherapy.

Related Concept Videos